The Efficacy of Reminders to Complete HPV Series (ICHAT)

University of Rochester

Status: Completed

Conditions: Improvement in Vaccine Intervals Between HPV Doses; Completion of Three Dose Series of HPV

Treatments: Other: Telephone reminder; Other: Text Message reminder

Study type: Interventional

Funder types: Other; Other U.S. Federal agency

Identifiers

NCT01731496

5K08HS017951-03

Details and patient eligibility

About

The human papillomavirus (HPV) vaccine is routinely recommended for both adolescent girls and boys starting at age 11, although it can be offered as young as 9 years of age. This is a 3-dose series and many adolescents do not complete it after getting the first dose. This study will study how effective it will be to send reminders to parents to schedule an appointment when their child is due for the next dose of HPV. Parents can chose whether they would like a phone call or text message reminder. This study will determine if the reminders work, and if one method is better than another (phone message vs. text message).

Enrollment: 749 patients

Sex: All

Ages: 10 to 21 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• Parents of adolescents aged 10 - 17 who have had at least 1 dose of HPV
• Patients aged 18 - 21 who have had at least 1 dose of HPV

Exclusion Criteria:

Trial design

Primary purpose: Health Services Research

Allocation: Randomized

Interventional model: Factorial Assignment

Masking: Single Blind

---

749 participants in 4 patient groups

Telephone reminder

Experimental group

Description:

Telephone message reminder to parents of adolescents whose child is due for a 2nd or 3rd dose of HPV vaccine.

Treatment:

Other: Telephone reminder

Text Message reminder

Experimental group

Description:

Text message reminder to parents of adolescents whose child is due for a 2nd or 3rd dose of HPV vaccine.

Treatment:

Other: Text Message reminder

Control: Telephone

No Intervention group

Control: Text Message

No Intervention group